Statute Details
- Title: Goods and Services Tax (Imports Relief) Order
- Act Code: GSTA1993-OR3
- Type: Subsidiary legislation (sl)
- Authorising Act: Goods and Services Tax Act (Cap. 117A), specifically sections 24(1), (2) and (3) and 86(1)
- Citation: O 3; G.N. No. S 104/1994 (with later revisions/amendments)
- Current version: Current version as at 27 Mar 2026
- Key provisions: Section 2 (definitions); Section 3 (certificates/permits); Section 4 (relief from GST on imports); Section 5 (value determination—exempt imports disregarded)
- Schedule: Lists (i) eligible organisations/persons, (ii) goods covered, (iii) conditions, and (iv) required documents/certificates/permits
What Is This Legislation About?
The Goods and Services Tax (Imports Relief) Order (“Imports Relief Order”) is a Singapore legal instrument that creates targeted relief from Goods and Services Tax (GST) payable on certain imported goods. In practical terms, it allows specified organisations or persons to import particular categories of goods without paying GST at importation—provided they meet the conditions and documentary requirements set out in the Order’s Schedule.
This is not a general GST exemption regime. Instead, it is a structured, schedule-driven relief mechanism. The relief is granted only to those who fall within the Schedule’s second column and only for the goods identified in the third column. The Schedule also specifies the conditions (fourth column) and the documents/certificates/permits that must be submitted (fifth column), subject to the Director-General of Customs’ discretion to require security and to impose additional revenue-protective conditions.
From a practitioner’s perspective, the Order is best understood as an administrative and compliance framework: it governs who can claim import GST relief, what goods are eligible, how relief is evidenced at customs clearance, and how the taxable value is treated when determining the value of goods for the purposes of the Schedule.
What Are the Key Provisions?
1. Definitions and interpretive anchors (Section 2)
Section 2 supplies key definitions used throughout the Order. These definitions are important because they tie the relief regime to other regulatory regimes and to customs administration. For example, the Order defines “customs office”, “customs station”, and “proper officer of customs” by reference to the Customs Act (Cap. 70). It also defines “Director-General” by reference to the Director-General of Customs appointment under the Customs Act.
Additionally, the Order includes definitions relevant to regulated medical and clinical trial contexts, such as “medicinal product”, “therapeutic product”, “regulated clinical trial”, and “protocol”. These cross-references indicate that some categories of eligible goods and/or eligible persons in the Schedule likely relate to health products and clinical research. For lawyers, the practical takeaway is that eligibility and documentation may require compliance with the Medicines Act and Health Products Act frameworks, not merely GST rules.
2. Documentary requirements at customs clearance (Section 3)
Section 3 provides a procedural rule: any certificate or permit required by the Order must be produced to the proper officer of customs at the time of customs clearance of the goods. This is a critical compliance point. Even where an importer is substantively eligible under the Schedule, failure to produce the required document(s) at the correct time can jeopardise the relief.
For practitioners advising importers, this means that GST import relief is not simply a post-clearance claim. It is an at-the-border clearance mechanism. Operationally, counsel should ensure that the importer’s customs broker and internal compliance team can identify the relevant Schedule item and have the required certificate/permit ready for presentation at clearance.
3. Relief from GST on importation—conditions, documents, security, and discretion (Section 4)
Section 4 is the core operative provision. Under Section 4(1), the organisations or persons specified in the Schedule’s second column are granted relief from the payment of GST on the importation of goods specified in the Schedule’s third column. However, that relief is expressly subject to multiple layers of requirements:
- (a) Conditions in the fourth column: The importer must satisfy the conditions specified in the Schedule.
- (b) Submission of documents/certificates/permits in the fifth column: The importer must submit the specified document(s) in the form and manner the Director-General may determine.
- (c) Furnishing security: The Director-General may require security in an amount he considers appropriate.
- (d) Further conditions: The Director-General may impose additional conditions for the protection of revenue.
Section 4(2) adds an important discretion: the Director-General may waive the requirement for a document/certificate/permit submission under Section 4(1)(b) if he considers it expedient. This is a relief-enabling flexibility, but it is discretionary. Practitioners should not assume waiver will be granted; instead, where documentary constraints exist (for example, delays in obtaining permits), counsel should consider engaging the relevant authority early and documenting the basis for any waiver request.
From a legal risk perspective, Section 4’s structure means that eligibility is not purely categorical. Even if the importer and goods match the Schedule, relief can still be withheld or conditioned based on compliance with the conditions, the documentary submission requirements, security requirements, and any additional revenue-protection conditions.
4. Determination of value—exempt imports disregarded (Section 5)
Section 5 addresses a valuation issue “for the avoidance of doubt”. Where, for the purpose of any item in the Schedule, the value of goods imported into Singapore needs to be determined, the value determination must ignore the value of any goods the import of which is an exempt import.
This provision is significant in mixed consignments or structured import arrangements where exempt and non-exempt goods may be imported together or where valuation calculations could otherwise incorporate exempt components. Section 5 clarifies that exempt imports should not inflate or affect the value base used for determining the GST position for the relevant Schedule item. For practitioners, this reduces ambiguity and supports a defensible valuation methodology that separates exempt components from the taxable/relief-relevant valuation.
How Is This Legislation Structured?
The Imports Relief Order is relatively short and is structured around a small number of operative sections supported by a detailed Schedule.
Sections:
- Section 1 (not reproduced in the extract but shown in the document): citation provision.
- Section 2: definitions and cross-references to other statutes and regulations.
- Section 3: procedural requirement to produce certificates/permits at customs clearance.
- Section 4: substantive relief grant mechanism, including conditions, documentary requirements, security, and Director-General discretion.
- Section 5: valuation clarification—exempt imports are disregarded when determining value for Schedule items.
Schedule: The Schedule is the practical “map” of the relief. It identifies:
- the eligible organisations/persons (second column),
- the goods covered (third column),
- the conditions to be met (fourth column), and
- the documents/certificates/permits required (fifth column).
In practice, most legal work under this Order involves interpreting the relevant Schedule entry and ensuring that the importer’s facts, documentation, and valuation approach align with that entry.
Who Does This Legislation Apply To?
The Order applies to “organisations or persons” specified in the Schedule. It is therefore not a universal exemption for all importers. Eligibility depends on whether the importer falls within the Schedule’s second column and whether the imported goods fall within the Schedule’s third column.
Because Section 2 includes definitions tied to customs administration and to health product/clinical trial regulatory regimes, the Schedule likely covers specific categories of importers and goods in regulated sectors (for example, therapeutic products or medicinal products connected to clinical trials). However, the precise scope is determined by the Schedule, and practitioners should always start by identifying the relevant Schedule item for the goods and importer in question.
Why Is This Legislation Important?
This Order matters because it directly affects the GST cost of importing eligible goods into Singapore. For businesses operating in sectors with regulated goods—particularly where permits, certificates, or clinical trial authorisations are involved—import GST relief can be financially material and can also influence supply chain planning and pricing.
Equally important, the Order is designed to be enforceable at the border. Section 3’s requirement to produce documents at customs clearance means that compliance failures can lead to GST being payable at importation, potentially creating cash-flow burdens and downstream accounting complications. Counsel should therefore treat this Order as both a legal and operational compliance instrument.
Finally, Section 4’s security and additional-condition powers, together with the Director-General’s discretion to waive document submission, means that the relief is not purely mechanical. Practitioners should anticipate that customs authorities may require security or impose additional conditions to protect revenue. Advising clients should therefore include a strategy for documentation, timing, and—where necessary—engagement with the Director-General/customs to manage documentary gaps or special circumstances.
Related Legislation
- Goods and Services Tax Act (Cap. 117A) — authorising provisions for import relief and related GST framework
- Customs Act (Cap. 70) — definitions and customs administration concepts (e.g., proper officer of customs, customs territory/stations)
- Health Products Act (Cap. 122D) — definitions relevant to health products and clinical trial regulatory context
- Medicines Act (Cap. 176) — definitions relevant to medicinal products
- Services Tax Act — referenced in the provided metadata (note: practitioners should confirm the exact linkage in the current consolidated legal framework)
- Customs (Offices and Stations) Regulations (Cap. 70, Rg 7) — definitions of customs offices/stations
- Medicines (Clinical Trials) Regulations 2016 (G.N. No. S 335/2016) — clinical trial certificate framework
- Health Products (Clinical Trials) Regulations 2016 (G.N. No. S 331/2016) — clinical trial authorisation/notification framework
- Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021 (G.N. No. S 104/2021) — definition of “Class 2 CTGT product”
Source Documents
This article provides an overview of the Goods and Services Tax (Imports Relief) Order for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.